Drugs / Magnesium Oxide
Magnesium Oxide
also known as
light magnesium oxide · E-530 · Heavy magnesium oxide · INS NO.530 · INS-530 · Mag ox · Mag-ox 400 · Magdose · +12 more
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | IRRIGATING SOLUTION G IN PLASTIC CONTAINER | — | 1982-06-22 | fda.gov ↗ |
Trials 14
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 02 trials | ||||||
| Phase 0 | NCT07700277 | Aug 2026 → Aug 2027 expected | intestinal disorder | Ottawa Hospital Research Institute | Not yet recruiting | No outcome recorded |
| Phase 0 | NCT03475693 | Sep 2017 → Nov 2019 | traumatic encephalopathy | Corewell Health South | Completed | No outcome recorded |
| Phase 22 trials · 1 missed | ||||||
| Phase 2 | NCT01439945 | Sep 2011 → Aug 2013 | breast cancer | Alliance for Clinical Trials in Oncology | Completed | Missed primary |
| Phase 2 | NCT01008904 | Jul 2009 → Jan 2013 | breast cancer | Virginia Commonwealth University | Completed | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT01984008 | Oct 2013 → Mar 2014 | — | Universal Integrated Corp. | Completed | No outcome recorded |
| Phase 3 | NCT01065857 | Jan → Jun 2010 | — | Laboratorios Casen-Fleet S.L.U. | Completed | No outcome recorded |
| Phase 44 trials | ||||||
| Phase 4 | NCT07173855 | Nov 2025 → Mar 2027 expected | — | Scarborough General Hospital | Recruiting | No outcome recorded |
| Phase 4 | NCT04161599 | Mar 2022 → Jun 2024 | — | Hospital Universitari Vall d'Hebron Research Institute | Unknown | No outcome recorded |
| Phase 4 | NCT03054805 | Sep → Dec 2014 | constipation disorder | Chang Gung Memorial Hospital | Completed | No outcome recorded |
| Phase 4 | NCT01481714 | Nov 2011 → Mar 2012 | — | Infante, Javier Molina, M.D. | Unknown | No outcome recorded |
| Phase not applicable4 trials · 1 met primary · 1 missed | ||||||
| — | NCT04033250 | Sep 2019 → Sep 2020 | — | Rambam Health Care Campus | Unknown | No outcome recorded |
| — | NCT03632590 | Mar 2018 → Jan 2020 | arterial disorder | University Medical Center Groningen | Unknown | Missed primary |
| — | NCT00538954 | Aug 2006 → Aug 2008 | metastasis from malignant tumor of colon | University of Edinburgh | Completed | Met primary |
| — | NCT00247715 | Oct 2003 → Jan 2007 | dyspepsia | Radboud University Medical Center | Completed | No outcome recorded |
| Comparator or background therapy5 trials | ||||||
| Phase 2 | NCT06260072 Comparator | Feb 2020 → Dec 2025 overdue | — | University of Virginia | Recruiting | No outcome recorded |
| Phase 2 | NCT01525875 Comparator | Aug 2012 → Mar 2015 | pseudoxanthoma elasticum (inherited or acquired) | Mark Lebwohl | Completed | No outcome recorded |
| Phase 3 | NCT03840226 Comparator | Aug 2019 → Jan 2026 | heart failure, magnesium deficiency | Sheba Medical Center | Unknown | No outcome recorded |
| Phase 3 | NCT03398031 Comparator | Jun 2017 → Mar 2018 | — | Ain Shams University | Unknown | No outcome recorded |
| Phase 4 | NCT00427492 Comparator | Jan 2007 → Jan 2009 | colon carcinoma | Hvidovre University Hospital | Completed | No outcome recorded |
Evidence & citations 23 cited values
Every value below carries the sentence it was read from. 20 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | magnesium oxide | “400 mg of Magnesium Oxide and 400 mg Riboflavin in capsule formation” NCT06260072 ↗ |
| Known as | E-530 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200572 ↗ |
| Known as | Heavy magnesium oxide | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200572 ↗ |
| Known as | INS NO.530 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200572 ↗ |
| Known as | INS-530 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200572 ↗ |
| Known as | light magnesium oxide | “Drug: Sodium picosulfate, light magnesium oxide, anhydrous citric acid 10 mg/3.5 g/10.97 g Oral” NCT04161599 ↗ |
| Known as | Mag ox | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200572 ↗ |
| Known as | Mag-ox 400 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200572 ↗ |
| Known as | Magdose | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200572 ↗ |
| Known as | Magnesia | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00427492 ↗ |
| Known as | Magnesia oxydata | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200572 ↗ |
| Known as | Magnesii oxidum | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200572 ↗ |
| Known as | Magnesium (as oxide) | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200572 ↗ |
| Known as | Magnesium oxide component of clenpiq | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200572 ↗ |
| Known as | Magnesium oxide component of prepopik | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200572 ↗ |
| Known as | Magnesium oxide heavy | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200572 ↗ |
| Known as | Magnesium oxide, light | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200572 ↗ |
| Known as | Magstar | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200572 ↗ |
| Known as | Oromag 160 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200572 ↗ |
| Known as | Oximag | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200572 ↗ |
| Known as | Uro-mag | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200572 ↗ |
| Modality | Small molecule | — CHEMBL1200572 ↗ |
| Route | Oral | “Patients receive oral magnesium oxide once daily in weeks 2-5.” NCT01008904 ↗ |